For the Inventor, By the Inventor

Enter assignee name

Belmont, MA, United States of America

The Mclean Hospital Corporation

USPTO Granted Patents = 125

% Expired Patents = 32.0

CIPO Patents = 4

EPO Patents = 17

Trademarks = 8

Forward Citations = 1,675

Loading Chart...

Loading Chart...

122 inventors (with patents filed for the assignee):

Perry F Renshaw (21 out of 27 patents)

Martin H Teicher (14 out of 19 patents)

Kwang-Soo Kim (10 out of 10 patents)

4. Ole Isacson (10 out of 10 patents)

5. John L Neumeyer (9 out of 20 patents)

6. Michael L Rohan (9 out of 11 patents)

7. Steven Bradley Lowen (8 out of 9 patents)

8. Ralph A Nixon (8 out of 11 patents)

9. Bruce M Cohen (7 out of 7 patents)

10. Aimee Parow (6 out of 6 patents)

11. Scott E Lukas (6 out of 6 patents)

12. Richard N Blazey (6 out of 35 patents)

13. David Lynn Patton (6 out of 204 patents)

14. Paige Miller (5 out of 11 patents)

15. Luis C Maas, Iii (5 out of 5 patents)

Core Competencies:

Parkinson's Disease

ADHD Diagnosis

Neuropsychiatric Therapy

Dopaminergic Neurons

Magnetic Field Stimulation

Gene Therapy

GABAergic Interneurons

Psychiatric Disorders

Stem Cell Therapy

Attention Deficit Hyperactivity Disorder

Drug Screening

Mitochondrial Replacement

125 patents: Sort by Forward Citations

1. 12584105 - AUTOLOGOUS CELL REPLACEMENT THERAPY FOR PARKINSON`S DISEASE (2026-03-24),

2. 12564610 - Human periventricular endothelial cell therapy for neuropsychiatric disorders (2026-03-03),

3. 12396988 - Methods of using muscarinic antagonists in the treatment of depression (2025-08-26),

4. 12241084 - Methods for efficient generation of GABAergic interneurons from pluripotent stem cells (2025-03-04),

5. 11898169 - Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors (2024-02-13),

6. 11767507 - Methods for efficient generation of GABAergic interneurons from pluripotent stem cells (2023-09-26),

7. 11026943 - Aminoquinoline derivatives and uses thereof (2021-06-08),

8. 11001809 - Synergistic genome-nonintegrating reprogramming by microRNAs and transcription factors (2021-05-11),

9. 10967073 - Glucocerebrosidase gene therapy for Parkinson's disease (2021-04-06),

10. 10912470 - System and method for tracking cerebral blood flow in fMRI (2021-02-09),

11. 10787669 - Antisense compounds targeting Leucine-Rich repeat kinase 2(LRRK2) for the treatment of Parkinsons disease (2020-09-29),

12. 10720242 - Systems and methods for modeling and predicting effective treatments for schizophrenia and other disorders (2020-07-21),

13. 10426969 - Magnetic field stimulation (2019-10-01),

14. 10370667 - Antisense compounds targeting leucine-rich repeat kinase 2 (LRRK2) for the treatment of parkinsons disease (2019-08-06),

15. 10201314 - System and method for evaluation of circulatory function (2019-02-12),

Company Overview

The McLean Hospital Corporation, located in Belmont, MA, specializes in the treatment and research of neuropsychiatric disorders. The institution is renowned for its innovative approaches to conditions such as Parkinson's disease and ADHD, utilizing advanced methodologies including neuropsychiatric therapy and gene therapy. McLean is at the forefront of exploring the roles of dopaminergic neurons and GABAergic interneurons, as well as employing techniques like magnetic field stimulation to enhance therapeutic outcomes for psychiatric disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

125 Patents

#1 in Belmont, MA

#169 in Massachusetts

#3,100 in US

#6,406 in the World

Belmont, MA, United States of America

The Mclean Hospital Corporation

Forward Citations = 1,675

122 inventors:

Perry F Renshaw (21 out of 27 patents)

Martin H Teicher (14 out of 19 patents)

Kwang-Soo Kim (10 out of 10 patents)

4. Ole Isacson (10 out of 10 patents)

5. John L Neumeyer (9 out of 20 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: The Mclean Hospital Corporation. Retrieved from https://idiyas.com/company/mclean-hospital

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…